Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.
Fettiplace A, Marcinak J, Merz M, Zhang HT, Kikuchi L, Regev A, Palmer M, Rockey D, Fontana R, Hayashi PH, Tillmann HL, Di Bisceglie AM, Lewis JH. Fettiplace A, et al. Among authors: hayashi ph. Aliment Pharmacol Ther. 2024 Nov;60(10):1293-1307. doi: 10.1111/apt.18271. Epub 2024 Sep 19. Aliment Pharmacol Ther. 2024. PMID: 39300766 Review.
Clinical characteristics and HLA associations of azithromycin-induced liver injury.
Conlon C, Li YJ, Ahmad J, Barnhart H, Fontana RJ, Ghabril M, Hayashi PH, Kleiner DE, Lee WM, Navarro V, Odin JA, Phillips EJ, Stolz A, Vuppalanchi R, Halegoua-DeMarzio D; Drug‐Induced Liver Injury Network (DILIN). Conlon C, et al. Among authors: hayashi ph. Aliment Pharmacol Ther. 2024 Sep;60(6):787-795. doi: 10.1111/apt.18160. Epub 2024 Jul 10. Aliment Pharmacol Ther. 2024. PMID: 38988034
Refinement of Hy's Law using the Drug-Induced Liver Injury Network Database.
Barritt AS, Hayashi PH, Stolz AA, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Barritt AS, et al. Among authors: hayashi ph. Am J Gastroenterol. 2024 Oct 18. doi: 10.14309/ajg.0000000000003145. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39422332
Diagnostic challenges in drug-induced liver injury.
Hayashi PH, Hoofnagle JH. Hayashi PH, et al. Clin Liver Dis (Hoboken). 2024 May 31;23(1):e0206. doi: 10.1097/CLD.0000000000000206. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38831765 Free PMC article. No abstract available.
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
Palmer M, Kleiner DE, Goodman Z, Brunt E, Avigan MI, Regev A, Hayashi PH, Lewis JH, Mehta R, Harrison SA, Siciliano M, McWherter CA, Vuppalanchi R, Behling C, Miller V, Chalasani N, Sanyal AJ. Palmer M, et al. Among authors: hayashi ph. Aliment Pharmacol Ther. 2024 Jan;59(2):201-216. doi: 10.1111/apt.17762. Epub 2023 Oct 25. Aliment Pharmacol Ther. 2024. PMID: 37877759
Vancomycin-Induced Liver Injury, DRESS, and HLA-A∗32:01.
Asif BA, Koh C, Phillips EJ, Gu J, Li YJ, Barnhart H, Chalasani N, Fontana RJ, Hayashi PH, Navarro VJ, Hoofnagle JH; Drug Induced Liver Injury Network (DILIN). Asif BA, et al. Among authors: hayashi ph. J Allergy Clin Immunol Pract. 2024 Jan;12(1):168-174.e2. doi: 10.1016/j.jaip.2023.09.011. Epub 2023 Sep 20. J Allergy Clin Immunol Pract. 2024. PMID: 37739311
Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, Rose SC, McGinty KA, Agala CB, Burke LM, Abate A, Altun E, Beyer C, Do J, Folkert MR, Forbes C, Hattangadi-Gluth JA, Hayashi PH, Jones K, Khatri G, Kono Y, Lawrence TS, Maurino C, Mauro DM, Mayo CS, Pak T, Patil P, Sanders EC, Simpson DR, Tepper JE, Thapa D, Yanagihara TK, Wang K, Gerber DA. Moon AM, et al. Among authors: hayashi ph. Hepatol Commun. 2023 Jun 14;7(7):e00184. doi: 10.1097/HC9.0000000000000184. eCollection 2023 Jul 1. Hepatol Commun. 2023. PMID: 37314737 Free PMC article.
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ, Aithal GP, de Boer YS, Liberal R, Gerbes A, Regev A, Terziroli Beretta-Piccoli B, Schramm C, Kleiner DE, De Martin E, Kullak-Ublick GA, Stirnimann G, Devarbhavi H, Vierling JM, Manns MP, Sebode M, Londoño MC, Avigan M, Robles-Diaz M, García-Cortes M, Atallah E, Heneghan M, Chalasani N, Trivedi PJ, Hayashi PH, Taubert R, Fontana RJ, Weber S, Oo YH, Zen Y, Licata A, Lucena MI, Mieli-Vergani G, Vergani D, Björnsson ES; IAIHG and EASL DHILI Consortium. Andrade RJ, et al. Among authors: hayashi ph. J Hepatol. 2023 Sep;79(3):853-866. doi: 10.1016/j.jhep.2023.04.033. Epub 2023 May 8. J Hepatol. 2023. PMID: 37164270 Free PMC article. Review.
129 results